Solid Biosciences Inc. — Director's Dealing 2021

Apr 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2021-04-27

Reporting Person: Freed Martin I (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-27	Stock Option (Right to Buy)	$5.23	A	25000	Acquired	2031-04-27	Common Stock (25000)	Direct

Footnotes

F1: This option was granted on April 27, 2021 and will vest in equal quarterly installments over the 12 month period following the grant date, subject to the continued service as a director or consultant.